title: Preservation of fertility in women undergoing reduced-intensity conditioning allogeneic transplantation with a fludarabine-based regime.
authors.forename: Sotirios G
authors.initials: SG
authors.lastname: Papageorgiou
authors.forename: Osman
authors.initials: O
authors.lastname: Ahmed
authors.forename: Nitish
authors.initials: N
authors.lastname: Narvekar
authors.forename: Melanie
authors.initials: M
authors.lastname: Davies
authors.forename: Panagiotis D
authors.initials: PD
authors.lastname: Kottaridis
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000097:blood; D004958:Estradiol / Q000097:blood; D005260:Female; D059247:Fertility Preservation; D043373:Follicle Stimulating Hormone, Human / Q000097:blood; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007247:Infertility, Female / Q000097:blood / Q000139:chemically induced / Q000503:physiopathology / Q000517:prevention & control*; D007986:Luteinizing Hormone / Q000097:blood; D019653:Myeloablative Agonists / Q000009:adverse effects*; D010053:Ovary / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D011247:Pregnancy; D018873:Pregnancy Rate; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D019172:Transplantation Conditioning / Q000009:adverse effects*; D014184:Transplantation, Homologous; D014463:Ultrasonography; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives*; D055815:Young Adult
chemical_list: D015415:Biomarkers; D043373:Follicle Stimulating Hormone, Human; D019653:Myeloablative Agonists; D004958:Estradiol; D007986:Luteinizing Hormone; D014740:Vidarabine; C024352:fludarabine